Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).

Institute of Psychiatry and Neurology, Warsaw · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
cognitive-assessmentmagnetic-resonance-imagingmultiple-sclerosis
multiple sclerosis, secondary progressive, multiple sclerosis, cladribine, multiple sclerosis secondary progressive, brain volume, quantitative susceptibility mapping, magnetic resonance imaging, cognitive assessment, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 873704
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.